Results 61 to 70 of about 1,216,387 (339)
Defibrillation threshold (DFT) testing is usually recommended after device implantation to confirm appropriate implantable cardioverter defibrillator (ICD)/cardiac resynchronization therapy defibrillator (CRT-D) function [1,2].
Toshiko Nakai, MD+6 more
doaj +1 more source
Combining Amplitude Spectrum Area with Previous Shock Information Using Neural Networks Improves Prediction Performance of Defibrillation Outcome for Subsequent Shocks in Out-Of-Hospital Cardiac Arrest Patients. [PDF]
OBJECTIVE:Quantitative ventricular fibrillation (VF) waveform analysis is a potentially powerful tool to optimize defibrillation. However, whether combining VF features with additional attributes that related to the previous shock could enhance the ...
Mi He+5 more
doaj +1 more source
The entirely subcutaneous implantable cardioverter-defibrillator (ICD) system was developed to provide a life-saving defibrillation therapy that does not affect the heart and vasculature.
Yusuke Kondo, M.D., Ph.D.+8 more
doaj +1 more source
Ventricular defibrillation using biphasic waveforms: The importance of phasic duration [PDF]
Biphasic waveforms can be used to defibrillate the heart with less energy than that used by monophasic waveforms. In 14 anesthetized open chest dogs with large contoured defibrillation electrodes, the effect on defibrillation efficacy of varying the ...
Dolker, Michael+5 more
core +1 more source
BACKGROUND To reduce myocardial damage caused by implantable cardioverter defibrillator (ICD) shock, the left axilla was studied as an alternative pulse generator implantation site, and compared with the traditional implantation site, the left anterior ...
M. Noro+18 more
semanticscholar +1 more source
The Circadian Variation of Atrial Defibrillation Thresholds
A circadian variation exists for ventricular defibrillation thresholds (DFTs) with a morning peak and a corresponding decrease in therapy success rates from implantable cardioverter defibrillators. Such a variation in atrial DFTs may have implications for the timing of internal cardioversion of atrial arrhythmias. The aim of this study was therefore to
Eduardo N. Warman+3 more
openaire +4 more sources
Background The placement of an implantable cardioverter defibrillator (ICD) has become routine practice to protect high risk patients from sudden cardiac death.
V. Semmler+9 more
semanticscholar +1 more source
Background The subcutaneous implantable cardioverter defibrillator (S-ICD) is an alternative to the transvenous implantable cardioverter defibrillator for the prevention of sudden cardiac death.
Yasuhisa Nakao+4 more
doaj +1 more source
Computer simulations show how low-intensity illumination can be used to terminate cardiac arrhythmias.
Eike M Wülfers+1 more
doaj +1 more source
Safety, Efficacy and Evidence Base for Use of the Subcutaneous Implantable Cardioverter Defibrillator [PDF]
The trans-venous implantable cardioverter defibrillator (TV-ICD) is effective in treating life-threatening ventricular arrhythmia and reduces mortality in high-risk patients.
Adduci, Carmen+2 more
core +2 more sources